Mouse models of advanced spontaneous metastasis for experimental therapeutics.
about
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomesNanotechnology: Future of OncotherapyRebuilding cancer metastasis in the mouseMouse models for studying angiogenesis and lymphangiogenesis in cancerDevelopment and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progressionRoutes of delivery for CpG and anti-CD137 for the treatment of orthotopic kidney tumors in miceMultiorgan metastasis of human HER-2+ breast cancer in Rag2-/-;Il2rg-/- mice and treatment with PI3K inhibitorAntiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia.Re-evaluate the effect of hyperbaric oxygen therapy in cancer - a preclinical therapeutic small animal model studyHuman tumor xenograft models for preclinical assessment of anticancer drug development.Development of Synthetic Aminopeptidase N/CD13 Inhibitors to Overcome Cancer Metastasis and Angiogenesis.Formalizing an integrative, multidisciplinary cancer therapy discovery workflowCo-targeting of DNA, RNA, and protein molecules provides optimal outcomes for treating osteosarcoma and pulmonary metastasis in spontaneous and experimental metastasis mouse modelsDMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2'3'-cGAMP, induces M2 macrophage repolarizationOn-chip human microvasculature assay for visualization and quantification of tumor cell extravasation dynamics.Accelerating cancer modeling with RNAi and nongermline genetically engineered mouse models.Genome-wide CRISPR screen in a mouse model of tumor growth and metastasisSerpins promote cancer cell survival and vascular co-option in brain metastasisA new mouse model for the study of human breast cancer metastasis.Blood vessel hyperpermeability and pathophysiology in human tumour xenograft models of breast cancer: a comparison of ectopic and orthotopic tumoursIn vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling.Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model.Integrative genomic and transcriptomic characterization of matched primary and metastatic liver and colorectal carcinoma.Neoadjuvant antiangiogenic therapy reveals contrasts in primary and metastatic tumor efficacy.Differential post-surgical metastasis and survival in SCID, NOD-SCID and NOD-SCID-IL-2Rγ(null) mice with parental and subline variants of human breast cancer: implications for host defense mechanisms regulating metastasis.Roles for endothelin receptor B and BCL2A1 in spontaneous CNS metastasis of melanoma.A model of postsurgical advanced metastatic breast cancer more accurately replicates the clinical efficacy of antiangiogenic drugs.The effect of chemotherapeutic agents on tumor vasculature in subcutaneous and orthotopic human tumor xenografts.Reversal of anchorage-independent multicellular spheroid into a monolayer mimics a metastatic model.Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase.Type III Collagen Directs Stromal Organization and Limits Metastasis in a Murine Model of Breast Cancer.Establishment of patient-derived xenograft models and cell lines for malignancies of the upper gastrointestinal tractCharacterization of two mouse models of metastatic pheochromocytoma using bioluminescence imaging.Vasculotide reduces endothelial permeability and tumor cell extravasation in the absence of binding to or agonistic activation of Tie2.Near infrared photoimmunotherapy for lung metastases.Human tumor xenografts: the good, the bad, and the ugly.Antiangiogenic therapy: impact on invasion, disease progression, and metastasis.Reappraising antiangiogenic therapy for breast cancer.Characterization of CC-531 as a Rat Model of Colorectal Liver Metastases.
P2860
Q24630783-224B99AF-BD49-45EA-AD7E-ABDCA61635B3Q26801067-B268A5CD-325B-4CF9-87C5-F94954DE45A0Q26864450-61C13983-E030-41B6-9E39-D55FE5B97D48Q27003898-4617A3CD-4FED-476F-B867-63B16C3EBB46Q27325140-EE15BE82-C24E-43AA-BE29-49DD96AFD197Q27335400-6872D6FF-E083-416D-925F-7AAF70F06EDEQ28728165-2248FF35-26CD-4C32-ACEF-3B56CD278D47Q30399006-8B20859E-DA2E-4C42-A992-EBC0958340C3Q30461128-689250D1-FD36-4EE3-982B-3170E595B515Q33554319-614D707A-2D2B-4911-9E59-0E9C8E25A18EQ33630608-A77E009B-86EE-42EF-A7B0-A3B3F09B55CAQ33693626-A28D307D-773C-4285-A5DA-4F1D0B0EF25AQ33761531-F2216464-FA2E-4ED1-97D8-B43B6F6A0AC0Q33773787-5709C8FE-D5B7-489D-88A1-E264E4B9582FQ33902543-6384B9D9-334B-405D-BE05-D7B8DC4E2673Q33914682-624C3296-897F-474E-AC78-2B9F4DFA0482Q34043392-FD7D5F3F-CE36-4680-8E13-C907D70B92F5Q34407528-E9B04A7D-A9D5-4EA3-95BE-34949AD808C8Q34464714-A4AAA670-EDEF-4FC7-A30E-AB41D3F332ACQ34502853-A6A26453-0974-475A-ADA2-C678C0C17566Q34541243-AAA85168-F4CB-4121-8F53-F5A65E567392Q34654565-ED615F11-D184-4245-B0EB-478A5611DBBEQ34701110-E82C3D0D-0E7D-47FB-A547-D656B3A657BBQ34780974-E72F7C76-FC39-4A27-9D6B-F36AAD40B73AQ34880943-F810D7EE-A6EF-4D01-B298-7DB9307B153DQ34963659-7041C571-440D-4505-BB7B-BCE4FDB7749CQ35101351-03F77F22-EA2C-4DD4-A3CF-EF42DD6E7D10Q35101358-5DA4D066-C21B-4A8F-9EE8-8739ED36F51DQ35187507-5F980631-60ED-4123-A154-4C8234B4B702Q35373200-5FE3EBE9-1924-4E58-A873-39DBA180F62BQ35532495-13707DD4-7DA4-42B9-9F2E-6E8883E6D574Q35568107-27F5EFC2-1C18-44D3-8150-E08EAAF34AFEQ35568684-1A291CF4-79CA-4C0E-A93F-FC3526DDF01AQ35661386-E57B253C-80A4-483B-8E58-94150934F0DEQ35695381-1EA9C6ED-B972-49DC-9A7A-C7D3C42DCFEBQ35869270-BAF91F06-29EB-4E6F-84D8-0B17339ACDBBQ35939496-CE5C34E0-617E-4982-AF7B-E75468238BB2Q35966757-951E8D4C-1ADB-472F-944F-EA49D38C050DQ35966766-41FD28CC-DC6F-40B1-ABD4-5DC5B869A0D2Q36015382-1092FFB4-C9AD-44BD-9107-9F98EAD7B657
P2860
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
@ast
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
@en
type
label
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
@ast
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
@en
prefLabel
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
@ast
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
@en
P2093
P2860
P356
P1476
Mouse models of advanced spontaneous metastasis for experimental therapeutics.
@en
P2093
Giulio Francia
Robert S Kerbel
William Cruz-Munoz
P2860
P2888
P304
P356
10.1038/NRC3001
P407
P577
2011-02-01T00:00:00Z
P6179
1005931214